Why the study?
Does E-4031 block the ATP-sensitive potassium channel in rabbit ventricular myocytes?
Does E-4031 block the ATP-sensitive potassium channel in rabbit ventricular myocytes?
E-4031 blocks the ATP-sensitive potassium channel from within the cytoplasm, acting as an open channel blocker of intermediate to slow time course.
Answers are grounded in this paper and cite their sources.
Suggests possible off-target IKATP effects in myocytes; leaves open in vivo relevance or impact on human electrophysiology.
The class III antiarrhythmic drug E-4031, a known blocker of the delayed rectifier potassium channel (IK), might also be capable of blocking the ATP-sensitive potassium channel (IKATP). We examined this possibility by studying the effect of E-4031 on single IKATP channels in membrane patches excised from ventricular myocytes that were obtained by standard enzymatic dissociation techniques from New Zealand white rabbits. In inside-out patches, E-4031 caused a dose-dependent block of IKATP with an EC50 of 31 +/- 1 microM, Hill coefficient of 0.89 +/- 0.24 and no effect on channel conductance. Open dwell-time kinetics were fitted by two exponential components, with E-4031 causing reduction of the longer time constant. In outside-out patches, the concentration of E-4031 required to produce blockade was much higher. We conclude that E-4031 blocks the ATP-sensitive potassium channel and that it does so from within the cytoplasm, with one-to-one channel binding stoichiometry. Single channel conductance is unchanged, but the longer time constant for the open state is reduced, which suggests that E-4031 may be an open channel blocker of intermediate to slow time course.
No takes yet. Share an insight, caveat, or question.
West et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: